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Abstract
Background/Aims: Matrix Metalloproteinases 2 is a key molecule in cellular invasion and metastasis. Mitochondrial
ROS has been established as a mediator of MMP activity. Coenzyme Q10 contributes to intracellular ROS regulation.
Coenzyme Q10 beneficial effects on cancer are still in controversy but there are indications of Coenzyme Q10
complementing effect on tamoxifen receiving breast cancer patients.
Methods: In this study we aimed to investigate the correlation of the effects of co-incubation of coenzyme Q10
and N-acetyl-L-cysteine (NAC) on intracellular H2O2 content and Matrix Metalloproteinase 2 (MMP-2) activity in
MCF-7 cell line.
Results and Discussion: Our experiment was designed to assess the effect in a time and dose related manner.
Gelatin zymography and Flowcytometric measurement of H2O2 by 2’7’,-dichlorofluorescin-diacetate probe were
employed. The results showed that both coenzyme Q10 and N-acetyl-L-cysteine reduce MMP-2 activity along with
the pro-oxidant capacity of the MCF-7 cell in a dose proportionate manner.
Conclusions: Collectively, the present study highlights the significance of Coenzyme Q10 effect on the cell
invasion/metastasis effecter molecules.
Introduction
Matrix Metalloproteinases (MMPs) belong to a multi-
gene family of enzymes that are mainly involved in phy-
siological alterations of Extracellular Matrix (ECM).
MMP-2 (Gelatinase A) and MMP-9 (Gelatinase B) are
key enzymes in the degradation of ECM collagen, there-
fore ECM remodeling. MMPs are secreted in the form
of inactive zymogens, which proceed to activation by
various pathways. Both expression and activity of MMPs
are regulated by diverse endogenous and exogenous sti-
muli (e.g. signals from cell-to-cell interaction and cellu-
lar microenvironment) [1].
The function of MMPs (especially MMP-2) is exten-
sively studied because of their pivotal role in pathogen-
esis of certain diseases. MMP-2 has long been
established as a marker in predicting phenotypes of
tumor including growth, progression and metastasis as
well as the dysregulated angiogenesis that is associated
with these events. As a result, MMPs have come to
represent important therapeutic and diagnostic targets
for the therapy and diagnosis of human cancers in
which their increase presages invasive phenotypes [2]
and [3].
MMPs are expressed in form of latent MMPs
(proMMP or zymogen) in response to exogenous sig-
nals, such as growth factors, cytokines, chemical agents
like phorbolesters, physical stress, oncogenic transforma-
tion, cell -cell and cell-matrix interactions. ProMMPs
are activated by disruption of the cysteine-zinc bond
(switch) or by cleavage of the propeptide by proteinases
such as plasmin, trypsin, kallikrein, chymase, and mast
cell tryptase. Some latent MMPs can also be activated
by another MMP. The disruption of the cysteine switch
by different organic and inorganic compounds, like
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and detergents results in autocatalytic cleavage of the
propeptide and a conformational change into catalyti-
cally active form [4].
As a consequence of the use of oxygen in aerobic
respiration, oxygen radicals are naturally produced in all
mammalian cells. Superoxide is generated within the
mitochondria and is sequentially reduced to hydrogen
peroxide (H2O2) and hydroxyl radicals. These radicals
damage DNA, producing the mutations that initiate
tumors and sustain progression.
Human tumor cell lines in vitro produce ROS at a far
greater rate. Markers for the constitutive oxidative stress
have been detected in samples from in vivo breast carci-
nomas and cell lines. 8-Hydroxy-2’-deoxyguanosine, one
of the major oxidatively modified DNA base products, is
almost ten times more prevalent in invasive ductal
breast carcinoma cells than in normal control samples
from the same patient [5]. The observed increase of
ROS in transformed cells is not only the incendiary of
further oxidative damage but also a mediator of certain
pathological signal transduction pathways. Several
important signal transduction pathways such as MAPK,
PI3K, Rho-GTPase and Smads cascades, are known to
mediate transcriptional regulation of metastasis-related
genes such as integrins and MMPs [6].
As a consequence to the general knowledge of ROS
implications in cancer, several studies have examined
the effect of individual and combinational antioxidant
dietary supplements on cancer outcome [7]. Despite
equivocal conclusions in certain areas, there are suppor-
tive publications that antioxidant regiments would com-
plement tamoxifen therapy in breast cancer patients in
various aspects [8].
Enthusiasm for introducing new phytochemicals and
supplements as potential therapeutic or preventive
agents for cancer and other pathologic conditions has
propelled researchers to study the behavior of key com-
ponents of malignancy in the presence of these antioxi-
dants. Therefore, evidence is rapidly mounting on the
effect of various novel antioxidants on MMPs activity/
expression in such studies [9] and [10]. However, the
majority of recently introduced antioxidants are hydro-
philic. This property delimits certain antioxidant appli-
cations, namely membrane passage and membrane
protections.
Among four major groups of natural lipid-soluble
antioxidants (carotenoids, tocopherols, estrogens and
coenzyme Q) only Coenzyme Q is mostly present in
reduced form. Coenzyme Q, in addition to membrane
lipids, protects proteins and DNA due to its ubiquitous
nature [11]. A lipid-soluble, endogenic, membrane-pro-
tective antioxidant, Coenzyme Q10 has been frequently
employed in studies on vascular and atherosclerotic
diseases. Consequently, its multiple roles in health and
disease are still under vast examination and review [12].
Its multiple-reductive enzymatic mechanisms and pre-
sence in mitochondrial membrane endows Coenzyme
Q10 an important place in the natural antioxidant
defense system. Since oxidative stress is a predominating
event in most pathological conditions, it is assumed that
in those conditions, Coenzyme Q amount increases as
an adaptive response to neutralize the pathogenic gener-
ated ROS. Moreover, in pathologic conditions, the
majority of coenzyme Q is in reduced form, showing
that the reductive enzymatic mechanism is not a limit-
ing factor [13].
In addition to the properties mentioned above, recent
findings in coenzyme Q10 capabilities to improve the
survival of progressed cancer patients had made coen-
zyme Q10 a potential candidate in our study [14].
Several authors have focused on effects of coenzyme
Q10 on breast cancer patients generally supporting the
idea of ameliorating effects of coenzyme Q10 in the
disease [15,16] and [17]. Alternatively, studies show
that baseline plasma Coenzyme Q10 levels are a
powerful and independent prognostic factor that can
be used to estimate the risk for pancreatic and mela-
noma progression [18] and [19]. Coenzyme Q10 effect
on MMPs has not been documented previously.
Therefore, in this study we aim to elucidate the effect
of exposure of a breast cancer cell line to exogenous
Coenzyme Q10 on expression/activity of MMP in the
microenvironment. To investigate this effect, we
employed MCF-7, a renowned model of cancerous
breast ductal epithelium [20].
Parallel to coenzyme Q10, we manipulated monothiol
antioxidant content. It has been proven that supplemen-
tation of certain thiol antioxidants has inhibitory effect
on MMP activity [21]. Therefore, we investigated the
effects of alterations in monothiol antioxidant content
by adding NAC and Buthionine Sulfoximine (BSO), a
substantial competitive inhibitor of g-glutamylcysteine
synthetase (g-GCS). BSO is a specific inhibitor of g-GCS
and is commonly employed to deplete the GSH content
of a cell [22] and [23]. We assumed that this would also
help us to obtain a better understanding of the regula-
tory effects of monothiol antioxidants (GSH and NAC)
on MMP-2 gelatinolytic action in the MCF-7 breast can-
cer cell line. To our knowledge, there is a paucity of
publication in which the effect of BSO on MMP-2 was
investigated.
Methods
Cells and reagents
MCF-7 cell lines derived from pleural metastasis of a
ductal human breast carcinoma were obtained from the
Iranian National Cell Bank. DMEM, L-glutamine, FCS
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ofluorescin-diacetate, Sodium bicarbonate, NAC, BSO
and Coenzyme Q10 were from Sigma. The liquids were
from Merck. After culturing HT1080 in a serum-free
medium for 48 hours, we collected the supernatants and
used them as a molecular weight marker of pro-MMP-2
and MMP-2 as described in literature [24].
Preparation of the reagents
NAC was dissolved in DMEM in serial concentrations
from 2 mM to 0.5 mM. Coenzyme Q10 was dissolved in
40° ethanol and added to DMEM in a sublethal concen-
tration of ethanol in 1×, 0.5 ×s and 0.25 ×s of 122 μM
concentrations. DMEM with similar concentrations of
ethanol was prepared for the control wells.
Preparation of MCF-7 samples
MCF-7 cells were cultured in DMEM supplemented
with 10% heat-inactivated FCS, antibiotics and 2 mm
L-glutamine at 37°C in a 7% CO2-humidified atmo-
sphere. Cells were routinely passaged twice a week at a
1:10 split ratio. From the 48 h cultured cells, 2 × 10
5
cell were seeded into each well of a 24-well culture
plate in the presence of 5% FCS, and incubated for 6,
15, 24 and 42 hours. By completion of the incubation
time, the media over the cells were aspirated and under-
went flowcytometric analysis. A portion of the media
was kept in -70°C for further analysis.
Fluorescent Measurement of H2O2 content
Hydrogen peroxide as a marker of cellular ROS produc-
tion was examined by a method dependent on intracellular
deacylation and oxidation of 2’,9 ’-dichlorodihydrofluores-
cein diacetate (DCHF-DA) to the fluorescent compound
2’,7 ’9-dichlorofluorescein (DCF). This probe is highly
reactive with H2O2 and has been used in evaluating ROS
generation in mammalian cells [25].
To assess the levels of intracellular ROS, flow cyto-
metric analysis was performed using the oxidative-sensi-
tive probe (DCFH-DA) as described [26]. Cells were
incubated for 30 minutes at 37°C in the presence of 5
mM DCFH-DA. After incubation, the cells were trans-
ferred to an ice bath, and the formation of 2’,7 ’-
dichlorofluorescein (DCF) was analyzed by flowcytome-
try using a Becton Dickinson Facscan with excitation
and emission settings of 495 and 525 nm, respectively.
Ten thousand viable cells from quadruple samples were
analyzed.
Gelatin Zymography
To assess the expression/activation of MMP-2, Sodium
Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis
(SDS-PAGE) substrate-embedded enzymography (zymo-
graphy) was carried out by a modification of the
method [27]. Briefly, SDS-PAGE gels were prepared for
mini-gels from 30:1 acrylamide/bis with the incorpora-
tion of gelatin (1 mg/ml) before casting. The gelatin gels
were routinely 7.5% acrylamide. Various denatured but
non-reduced samples and standards were then run into
the gels at constant voltage of 150 V under non-redu-
cing conditions. When the dye fronts reached a point
approximately 0.5 cm from the bottom of the gels, the
gels were removed and subjected to the following wash-
ing protocol: twice for 30 minutes each time in 50 mM
Tris buffer (containing 1 mM Ca
2+ and 0.5 mM Zn
2+)
with 2.5% Triton X-100; once for 5 minutes in Tris buf-
fer alone and finally overnight in Tris buffer with 1%
Triton X-100 [28].
The molecular weight marker of pro-MMP-2 and
MMP-2 and inhibitors were added to the overnight
wash. Then the gels were stained with Coomassie Brilli-
ant Blue 250-R. After destaining, zones of enzyme activ-
ity showed up as regions of negative staining. Relevant
controls included samples incubated with EDTA (MMP
inhibitors), PMSF (serine proteinase inhibitor), E64
(cysteine proteinase inhibitor) and pepstatin (aspartic
proteinase inhibitor). HT1080 culture supernatant was
used as the molecular weight marker of pro-MMP-2
and MMP-2 [29].
Statistical analysis
Values were expressed as MMP-2 activity percentage of
control samples, means and standard errors. For effec-
tiveness and dose-response studies, differences among
groups were evaluated with two-way analysis of variance
(ANOVA). If the F-value was significant, groups were
then compared at each dose by one-way analysis of
variance (ANOVA) followed by Dunnett’s C test (non-
homogenous variances) and Schaffe (homogenous
variances) Post Hoc analysis. Bivariate correlation one-
tailed Spearman tests were performed for the determina-
tion of correlation between H2O2 vs. supplement
concentration and H2O2 vs. MMP-2 activity. If a p
value was less than 0.05, a difference was considered sig-
nificant. Statistical analysis was carried out using SPSS
16.0 program.
Results
In order to determine the effect and correlation of the
dose of NAC, BSO and coenzyme Q10 on H2O2 content
variations, we measured the extracellular H2O2 of maxi-
mum, half and quarter-maximum dose on MCF-7 by
the DCHF flowcytometric method. The experiment was
repeated for different periods of exposure. Results were
then compared to the control (null drug) by subtracting
the emission of controls (null drug) from the emission
of the samples to calculate the variations of H2O2
content.
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coenzyme Q10 in different time courses on MMP-2
activity of MCF-7 cell line, standard gelatin zymography
was performed, and the density of the developed bands
were measured and compared with the control sample
in each dose and exposure time via post hoc test.
Finally, we measured the correlation between H2O2 con-
tent and MMP-2 activity, and drug dose and MMP-2
activity by the Spearman correlation test.
In the case of NAC, correlation was observed between
NAC concentration as a thiol antioxidant and the
amount of H2O2 content in different exposure time
courses. Flowcytometeric measurements of H2O2 by
emissions of DCHF revealed large correlation (-0.710 in
the first 15 hours -0.775 after 24 hours all p < 0.05)
with the amount of thiol antioxidant NAC. Results for 6
and 42 hours show a large correlation, however they
were not statistically significant.
In 6 and 15 hours of supplementation, mean MMP-2
activity showed significant (p < 0.05) difference in all
groups compared to the control group. In full dose
NAC vs. control, MMP-2 activity showed a difference of
58.97%, 52.4% and 28.16% in 6, 15 and 42 hours respec-
tively. Coefficents of -0.946, -0.621 and -0.650 correla-
tion coefficient in 6, 15 and 42 hour respectively (p <
0.05) were calculated by correlation analysis. Also a
positive medium correlation was observed between con-
tent and MMP-2 activity (p < 0.05).
Following Ortega et al experiments on cell lines, in
this study, we employed 0.2 mM concentration for BSO
to effectively inhibit g-GCS and to decrease the intracel-
lular content of GSH [30].
The results showed that merely in the first 6 hours of
exposure, BSO was effective to increase the content of
the cell. At 6 hours, the flowcytomertic analysis showed
a positive 0.798 correlation coefficient between H2O2
increase and dosage (p < 0.05). In these samples, only
the concentration of 0.1 mM had a significant increase
(20%, p < 0.05) of MMP-2 activity in comparison with
control samples by Post Hoc analysis. Although incuba-
tion for 6 and 15 hours showed significant increase (p <
0.05) on MMP-2 activity in ANOVA tests, incubation
for more than 15 hours had no significant effect of
MMP-2 gelatinolytic activity. (Samples incubated for 24
and 42 hours did not show significant dose-responsive
correlation with either H2O2 content or MMP-2
activity.)
Coenzyme Q10
In this study we used 122 μMo fC o e n z y m eQ 10,w h i c h
according to pilot studies had shown no apoptotic or
cytotoxic effect on the cells. DCF fluorescence measure-
ments revealed that there is a strong negative correla-
tion between Coenzyme Q10 dose and H2O2 content.
Accordingly, 24 and 42 hours of MCF-7 cells exposure
to coenzyme Q10, illustrated a significant decline of
H2O2 content with a correlation coefficient of -0.926
and -0.739 (p value < 0.05) respectively (Figure 1).
Samples supplemented merely with Coenzyme Q10 for
24 and 42 hours showed significant change in MMP-2
gelatinolytic activity (p < 0.05) (Figure 2). In 24 hours of
supplementation, full and quarter dose showed signifi-
cant (p < 0.05) differences compared to control group
mean. Post hoc analysis of samples after 42 hours of
incubation revealed significant (p < 0.05) decrease in
mean MMP-2 activity when full dose and quarter dose
Coenzyme Q10 was used. Interestingly, full dose in 42
hours was the only group among Coenzyme Q10 supple-
mented samples that showed less MMP-2 activity
compared to control group mean. In correlation analy-
sis, both 24 hours and 42 hours showed large negative
correlations (-0.650 and -0.946, p < 0.05) respectively
(Figure 2. Panel A).
Finally, statistical analysis of H2O2 content and MMP-
2 activity revealed that there are good correlations
(24 hours: 0.772; 42 hours: 0.804, p < 0.05) between
H2O2 content and MMP-2 gelatinolytic activity (Figure
2. Panel B). In other words, this shows that when sup-
plemented with Coenzyme Q10, extracellular activity of
MMP-2 in MCF-7 cell line is proportionate to H2O2
concentration.
After 24 and 42 hours of exposure to Coenzyme Q10,
both groups at full dose showed significant (p < 0.05) 22
and 24% decrease compared to control group (illustrated
in Figure 3).
Discussion
In the current study, MMP-2 activity as a marker of
malignancy was investigated in the presence of various
substances that have been shown to play a pivotal role
in maintaining the redox status of the cell (namely
coenzyme Q10 and GSH). Hydrogen peroxide, as an
abundant ROS in the cell, was the target of manipula-
tion and measurement.
Nelson et al have carefully reviewed aspects of MMPs
activation and regulation by redox status. ROS is consid-
ered one of the major routes of MMP regulation
through oxidation of the zinc-cysteine switch. It is clear
that ROS, particularly H2O2, play fundamental roles in
modulating the various kinase cascades, phosphatase
activity, transcription factor binding and MMP latency.
Although there are many likely candidates, the specific
signaling molecules that are directly modified by ROS
and lead to MMP expression have yet to be clearly
determined [31].
Sandhya and Mishra had used a concentration of 100
μM for NAC directly on MCF-7 as a suitable non-
cytotoxic concentration. In the present experiment, we
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dency and the correlation between supplement doses vs.
H2O2 concentration [32].
In almost all exposure times, large correlation was
found between NAC and H2O2 concentrations (15 and
24 hours: p < 0.05, 6 and 42 hours: p > 0.05). ROS was
decreased in dose-dependent fashion. This finding was
majorly consistent with previous studies. MMP-2
gelatinolytic activity showed a significant (p < 0.05)
decrease in all incubation times; and according to our
observations this decrease was also in a dose-responsive
manner in almost all of the incubation times.
Interestingly, regarding MMP-2 activity change with
NAC pretreatment, highest mean difference between
groups and the largest correlation (-0.946, p < 0.05) was
observed in the first 6 hours of incubation. This
Figure 1 Measurements of DCF fluorescence as a marker of Hydrogen Peroxide content in the medium after incubating for 24 and 42
hours with serial dilutions of Coenzyme Q10. The numbers represent the percentage of control samples mean.
P a n e l   A         
←   ←
Panel B  
   
Figure 2 Panel A. Zymogram charts representing gelatinolytic activity measured by standard gel zymography in 24 and 42 hours of
exposure of cells to coenzyme Q10. The arrows point to the row of bands of gelatin digestion. Double bands represent 72 KD MMP-2 and 92
KD proMMP-2. Panel B. Statistical analysis presentation of corresponding zymograms: numbers on the y axis represent the percentage of control
samples mean.
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between NAC and H2O2 could indicate that in MCF-7
cell the effect of NAC tends to be more radical scaven-
ging rather than biological inhibiting or inducing. This
idea could be supported by the observed positive corre-
lation between H2O2 and MMP-2 activity (p < 0.05).
These findings are partly consistent with reports of Vor-
onkina et al who stated that the effect of NAC on the
activities of MMP secreted by normal (3T3) and trans-
formed (3T3-SV40) mouse fibroblasts by supplementa-
tion with NAC for 2-6 hours completely inhibited
MMP-2 and MMP-9 activity in both cell lines. They
speculated that the inhibition was independent of NAC
concentration at the range of 1-10 mM [33].
Similarly, the decline of MMP-2 activity in the presence
of NAC could be due to the protection of cysteine switch
by this monothiol. This postulation is congruent with
observations of Bogani et al who used 5 mM NAC [34].
As the most important thiol antioxidant components,
glutathione is a tri-peptide involved in converting
H2O2 to water. It functions very closely to NAC which
is itself a precursor of glutathione. Its roles have
undergone extensive research in areas of prevention
and therapy of cancer; it has been shown that MMP-1
mRNA and MMP-2 and -9 activities are inhibited by
glutathione in human fibroblasts and liver allografts,
respectively. Glutathione has been shown to induce
MMP-1 and -2 expressions in human heart fibroblasts.
Conversely, in transformed fibroblasts, glutathione
inhibited MMP-1 and -2 expressions and increased
TIMP-2 expression. Altogether these findings advocate
the role of oxidative stress in cancer [35]. N-acetylcys-
teine has been reportedly able to block the TNF- and
high-glucose mediated induction of MMP-9 mRNA
and protein as well as the activities of MMP-2 and -9
in human fetal membranes [36].
To investigate its GSH depleting effect on activity/
expression of MMP-2, we pretreated cells with BSO (a
glutathione synthesis inhibitor). BSO prooxidant beha-
vior was only significant in the first 6 hours of incuba-
tion (BSO vs. H2O2). Also in this period, a significant
20% increase (p < 0.05) of MMP-2 activity was observed.
Incubations more than 6 hours did not show any signifi-
cant change in either H2O2 or MMP-2 activity. It is pos-
sible that after 6 hours, GSH synthesis had resumed by
the translation of enzyme g-glutamylcysteine synthetase
or compensation by increasing the rate of antioxidant
recycling or other antioxidants synthesis.
Brennisen and Wank et al have proposed that the
inhibition of catalase by aminotriazol (ATZ), inhibition
of GSHPx by buthionine sulfoximine (BSO), and block-
ing the Fenton reaction by the iron chelator desferrioxa-
mine (DFO) in concert led to an increase in steady-state
MMP-1 mRNA levels, possibly dependent on intracellu-
lar H2O2 increase [37]. In a later study, Wenk et al
reported increase in basal MMP-1 expression in conse-
quence of H2O2 increase as the mediator of cell signal-
ing [38]. From these observations it could be concluded
that BSO acts on MMP as a secondary targets via altera-
tion of ROS content of the cell.
Coenzyme Q10 has been suggested as the most impor-
tant antioxidant against H2O2. Since the cytoplasmic
membrane is permeable to H2O2,i ti st ob ea s s u m e d
that H2O2 measured in the microenvironment repre-
sents an approximation of intracellular content of H2O2.
In addition, supplemented Coenzyme Q10 has been
shown to consist a fraction of Mitochondrial Coenzyme
Q10 [13]. Moreover, Coenzyme Q10 action against other
elements of acute inflammation has been shown in in-
vitro studies [39].
To our knowledge, this is the first time that the effect
of Coenzyme Q10 on MMP activation/expression has
Figure 3 Illustrations of MMP-2 and DCF fluorescence emission as a marker for H2O2 content. Despite similar trends, H2O2 in both charts
is below control levels. However, at 122 μM coenzyme Q10, MMP-2 shows lower activity than control only at 42 hours.
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other parallel experiment to compare our observation.
According to our observations, supplementation with
Coenzyme Q10 increased the H2O2 content of cellular
environment in 6 and 15 hours of incubations at all
doses (data not shown). After 24 and 42 hours of expo-
sure to Coenzyme Q10, both groups at full dose showed
significant (p < 0.05) 22 and 24% decrease compared to
control group (illustrated in Figure 3), respectively. We
assume two mechanisms could be accounted for this
phenomenon. First, it could be due to oxidative stress
c a u s e db yh i g hd o s ee x p o s u r eo fe x o g e n o u sC o e n z y m e
Q10. As indicated previously in this text, Coenzyme Q10
freely passes through membranes and, to certain extent,
would disrupt the delicately tuned superoxide anion/
H2O2 signaling pathways [40,41] and [42].
Therefore, longer exposures were needed for the cells
to adapt to the new redox state. Secondly, it is well
known that Coenzyme Q10 possesses pro-oxidant prop-
erties which, in turn, greatly contribute to sustaining the
physiological redox potential of the cytoplasm and
membranes. Accordingly, generating the superoxide
anion/H2O2 as second messengers in signaling systems
are affected [41]. Our data suggest that pro-oxidant
behavior of Coenzyme Q10 could have contributed to
the increased H2O2 content observed. It may be possible
that in the case of incubation time over 24 hours,
enough time was given to the cells to establish a new
equilibrium, thus decrease the overall H2O2 content of
the ECM. It is to highlight that due to their molecular
properties, both Coenzyme Q10 and H2O2 would face
little hindrance for passing the lipid membranes.
In addition to widely accepted effects of H2O2 on MMP
activity, causal role of H2O2 and quelling role of antioxi-
dants on the expression of MMP mRNAs have been fre-
quently demonstrated in numerous original reports and
reviews [37] and [42]. In line with these findings, we
assume similar mechanisms may have played a role in
the current study. The studied novel modulatory effect of
Coenzyme Q10 on MMP activity/expression might be
mainly due to Coenzyme Q10 interaction with ROS med-
iators. However, further expression studies need to eluci-
date the exact mechanisms of this interaction.
Conclusions
Taken together, the present study highlights the signifi-
cance of Coenzyme Q10 effect on the cell invasion/
metastasis effecter molecules.
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